<DOC>
	<DOCNO>NCT01257412</DOCNO>
	<brief_summary>This study intend compare efficacy safety dapagliflozin versus placebo treatment-naïve subject type 2 diabetes inadequate glycaemic control diet exercise alone .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Dapagliflozin Monotherapy Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet Exercise Alone</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Provision inform consent participate study Diagnosed type 2 diabetes ( high blood sugar ) ; HbA1c ≥ 7.2 % ≤10.0 % Subjects drug naïve Women childbearing potential comply use adequate method contraception avoid pregnancy throughout study &amp; negative serum urine pregnancy test Subjects receive Insulin therapy within one year enrollment Subjects severe uncontrolled hypertension Subjects history unstable rapidly progress renal disease Subjects severe liver disease Subjects receive treatment Human immunodeficiency virus ( HIV )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Phase III</keyword>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>inadequate glycaemic control</keyword>
</DOC>